Newsflow expected this quarter :
- Bioequivalence Trial scheduled to commence first QTR 2024 (~FEB)
- The trial only takes 5 days.
- First patient enrolments
- First patient dosing
- Last patient dosing
- Trial results – say 30 days post
- They then plan for first sales under special access in Australia in 2nd QTR 2024 (based on trial results), and move immediately to apply registration with the FDA (US).
Newsflow expected this quarter : Bioequivalence Trial scheduled...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
73.0¢ |
Change
0.030(4.29%) |
Mkt cap ! $51.39M | |||
| Open | High | Low | Value | Volume |
| 71.5¢ | 74.5¢ | 70.0¢ | $131.8K | 183.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7764 | 73.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 74.5¢ | 3998 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| LTP (ASX) Chart |